Watchlist For March 11: COOL, CBP, OPK

Majesco Entertainment Co. ( NASDAQ:COOL ) reported an increase in profit for
the first quarter as compared to same period last year, driven mainly by higher
revenues and better margins. The company's  net income for the quarter rose
to $6.76 million or $0.18 per share from $3.81 million or $0.10 per share in the
first quarter of previous year. The non-GAAP net income increased to $7.5
million or $0.20 per share from $2.9 million or $0.08 per share last year. The
company reported net revenues surged 66 percent to $48.47 million from $29.21
million in the comparable quarter a year ago, increased by the successful
launches of Zumba Fitness and Babysitting Mama. The gross margin increased to
40.5 percent from 29.8 percent last year, primarily driven by the higher price
points of Zumba Fitness, compared with the companys Wii and DS titles a year
ago. The company expects net revenue in a range of $100 million to $110 million
for 2011, up from the prior range of $85 to $90 million. The adjusted earnings
is expected in the range of $0.20 to $0.25 per share range, compared to previous
range of $0.06 to $0.10 per share. Majesco Entertainment stock is currently
trading at $2.77. The stock is up 11.69 percent from its previous close. Majesco
Entertainment stock touched the high of $2.84 and lowest price in today's
session is $2.35. The company stock's beta is 1.41. The company stock has
traded in the range of $0.49 and $2.84 during the past 52 weeks. The company's
market cap is $110.66 million. China Botanic Pharmaceutical Inc. ( AMEX:CBP )
reported fourth quarter results, with net sales increased 15.2% to $16.7
million, from $14.5 million during the same period in 2009. The rise was mainly
due to growing market acceptance and resulting increased sales volume of the
companys new products. The net income declined by 3.0% to $5.6 million, or $0.14
per diluted share, from $5.8 million, or $0.15 per diluted share in the prior
year period. For the full year, the company reported net sales were $55.2
million, an increase of 27.1% from $43.4 million in fiscal 2009. The increase in
sales was mainly due to the launch of new OTC medicines, increased demand and
strong market acceptance of the companys products, effective marketing efforts
and product price increases. The net income was $17.9 million, or $0.44 per
diluted share, an increase of 20.4% from $14.8 million, or $0.41 per diluted
share, for the same period a year ago. The company expects net sales and net
income to grow at 28% to 30% for 2011. China Botanic Pharmaceutical stock is
currently trading at $1.84. The stock is down 3.16 percent from its previous
close. China Botanic Pharmaceutical stock touched the high of $1.92 and lowest
price in today's session is $1.76. The company stock's beta is 1.83. The
company stock has traded in the range of $1.26 and $3.00 during the past 52
weeks. The company's market cap is $68.52 million. Opko Health Inc. ( AMEX:OPK
) announced its plans to offer and sell $100 million of its common stock in an
underwritten public offering. The company has also plans to grant the
underwriters an option to purchase up to an additional $15 million of common
stock offered to cover overallotments of shares, if any. The company intends to
use the net proceeds of the offering for general corporate purposes, which may
include research and development expenses, clinical trials, the acquisition of
new technologies and businesses and other business opportunities. Opko Health
stock is currently trading at $3.72. The stock is up 5.38 percent from its
previous close. Opko Health stock touched the high of $3.74 and lowest price in
today's session is $3.50. The company stock has traded in the range of $1.80
and $5.03 during the past 52 weeks. The company's market cap is $949.93
million.